21 years of historical data (2005–2025) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
The Ensign Group, Inc. trades at 36.7x earnings, 36% above its 5-year average of 27.0x, sitting at the 100th percentile of its historical range. Compared to the Healthcare sector median P/E of 23.7x, the stock trades at a premium of 55%. On a free-cash-flow basis, the stock trades at 33.4x P/FCF, 16% above the 5-year average of 28.9x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $12.4B | $10.3B | $7.7B | $6.4B | $5.4B | $4.8B | $4.1B | $2.5B | $2.0B | $1.1B | $1.1B |
| Enterprise Value | $14.0B | $11.8B | $9.2B | $7.8B | $6.6B | $5.8B | $4.9B | $3.8B | $2.2B | $1.4B | $1.3B |
| P/E Ratio → | 36.67 | 29.83 | 25.95 | 30.74 | 23.95 | 24.55 | 23.83 | 23.03 | 21.34 | 26.96 | 21.64 |
| P/S Ratio | 2.45 | 2.03 | 1.82 | 1.72 | 1.78 | 1.82 | 1.69 | 1.25 | 1.12 | 0.69 | 0.65 |
| P/B Ratio | 5.64 | 4.59 | 4.20 | 4.30 | 4.31 | 4.68 | 4.97 | 3.87 | 3.28 | 2.19 | 2.35 |
| P/FCF | 33.45 | 27.66 | 40.95 | 23.78 | 29.09 | 23.19 | 12.59 | 21.05 | 12.70 | 69.47 | 132.23 |
| P/OCF | 21.97 | 18.18 | 22.29 | 17.08 | 19.74 | 17.34 | 10.90 | 13.21 | 9.38 | 15.03 | 14.65 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
The Ensign Group, Inc.'s enterprise value stands at 26.4x EBITDA, 27% above its 5-year average of 20.8x. The Healthcare sector median is 13.8x, placing the stock at a 90% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.34 | 2.17 | 2.09 | 2.19 | 2.20 | 2.06 | 1.88 | 1.25 | 0.86 | 0.79 |
| EV / EBITDA | 26.37 | 22.32 | 20.90 | 23.78 | 18.48 | 18.27 | 17.81 | 21.24 | 16.84 | 15.60 | 10.03 |
| EV / EBIT | 32.83 | — | 23.45 | 27.75 | 22.27 | 21.83 | 21.79 | 29.03 | 25.14 | 30.52 | 14.08 |
| EV / FCF | — | 31.88 | 48.94 | 28.81 | 35.89 | 28.05 | 15.31 | 31.72 | 14.07 | 86.62 | 159.81 |
Margins and return-on-capital ratios measuring operating efficiency
The Ensign Group, Inc. earns an operating margin of 8.4%. Operating margins have expanded from 6.8% to 8.4% over the past 3 years, signaling improving operational efficiency. ROE of 16.9% indicates solid capital efficiency. ROIC of 8.9% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 20.5% | 20.5% | 15.7% | 15.8% | 17.1% | 17.8% | 17.0% | 14.3% | 12.5% | 10.8% | 11.4% |
| Operating Margin | 8.4% | 8.4% | 8.4% | 6.8% | 9.8% | 9.9% | 9.3% | 6.3% | 4.8% | 2.7% | 5.6% |
| Net Profit Margin | 6.8% | 6.8% | 7.0% | 5.6% | 7.4% | 7.4% | 7.1% | 5.4% | 5.3% | 2.5% | 3.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 16.9% | 16.9% | 17.9% | 15.3% | 19.8% | 21.2% | 23.1% | 17.6% | 16.8% | 8.4% | 11.3% |
| ROA | 6.8% | 6.8% | 6.7% | 5.5% | 7.1% | 7.2% | 6.9% | 6.2% | 8.1% | 3.8% | 5.7% |
| ROIC | 8.9% | 8.9% | 8.7% | 7.1% | 9.8% | 10.5% | 9.2% | 7.0% | 8.0% | 4.4% | 11.8% |
| ROCE | 10.0% | 10.0% | 9.7% | 8.1% | 11.4% | 12.1% | 11.2% | 8.8% | 9.5% | 5.2% | 13.5% |
Solvency and debt-coverage ratios — lower is generally safer
The Ensign Group, Inc. carries a Debt/EBITDA ratio of 3.9x, which is moderately leveraged (26% above the sector average of 3.1x). Net debt stands at $1.6B ($2.1B total debt minus $504M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.93 | 0.93 | 1.07 | 1.25 | 1.26 | 1.24 | 1.36 | 2.05 | 0.40 | 0.63 | 0.62 |
| Debt / EBITDA | 3.91 | 3.91 | 4.46 | 5.71 | 4.38 | 4.00 | 4.01 | 7.47 | 1.87 | 3.57 | 2.17 |
| Net Debt / Equity | — | 0.70 | 0.82 | 0.91 | 1.01 | 0.98 | 1.07 | 1.96 | 0.35 | 0.54 | 0.49 |
| Net Debt / EBITDA | 2.95 | 2.95 | 3.41 | 4.15 | 3.50 | 3.17 | 3.16 | 7.14 | 1.63 | 3.09 | 1.73 |
| Debt / FCF | — | 4.22 | 7.99 | 5.03 | 6.80 | 4.87 | 2.72 | 10.67 | 1.37 | 17.14 | 27.59 |
| Interest Coverage | — | — | 43.24 | 31.58 | 33.24 | 38.03 | 23.84 | 8.25 | 5.59 | 3.17 | 12.87 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.42x means The Ensign Group, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.42 | 1.42 | 1.56 | 1.42 | 1.34 | 1.22 | 1.04 | 1.20 | 1.29 | 1.63 | 1.58 |
| Quick Ratio | 1.42 | 1.42 | 1.56 | 1.42 | 1.34 | 1.22 | 1.04 | 1.20 | 1.29 | 1.63 | 1.58 |
| Cash Ratio | 0.56 | 0.56 | 0.71 | 0.72 | 0.57 | 0.53 | 0.44 | 0.22 | 0.15 | 0.25 | 0.33 |
| Asset Turnover | — | 0.93 | 0.91 | 0.89 | 0.88 | 0.92 | 0.94 | 0.86 | 1.48 | 1.45 | 1.65 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 45.97 | 48.82 | 47.47 | 49.27 | 45.67 | 46.34 | 55.38 | 52.40 | 60.53 | 53.91 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
The Ensign Group, Inc. returns 0.1% to shareholders annually — split between a 0.1% dividend yield and 0.0% buyback yield. The earnings yield of 2.7% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.4% | 0.5% | 0.8% | 0.8% |
| Payout Ratio | — | — | 4.6% | 6.2% | 5.4% | 5.9% | 6.4% | 9.2% | 10.2% | 21.5% | 16.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.7% | 3.4% | 3.9% | 3.3% | 4.2% | 4.1% | 4.2% | 4.3% | 4.7% | 3.7% | 4.6% |
| FCF Yield | 3.0% | 3.6% | 2.4% | 4.2% | 3.4% | 4.3% | 7.9% | 4.8% | 7.9% | 1.4% | 0.8% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.6% | 0.2% | 0.6% | 0.3% | 0.1% | 0.7% | 2.8% |
| Total Shareholder Yield | 0.1% | 0.2% | 0.2% | 0.2% | 0.8% | 0.5% | 0.9% | 0.7% | 0.6% | 1.5% | 3.5% |
| Shares Outstanding | — | $59M | $58M | $57M | $57M | $57M | $56M | $56M | $54M | $53M | $52M |
Compare ENSG with 6 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| ENSGYou | $12B | 36.7 | 26.4 | 33.4 | 20.5% | 8.4% | 16.9% | 8.9% | 3.9 |
| EHC | $11B | 19.4 | 10.1 | — | 47.5% | 12.8% | 18.5% | 12.7% | 0.2 |
| BKD | $4B | -13.7 | 10.2 | 16.7 | 88.9% | 2.7% | -308.5% | 2.0% | 2.6 |
| NHC | $3B | 21.3 | 15.1 | 17.1 | 37.3% | 8.7% | 11.7% | 8.4% | 0.5 |
| SEM | $2B | 12.9 | 20.3 | 4.8 | 11.5% | 0.0% | 7.3% | 0.0% | 7.4 |
| PNTG | $1B | 40.1 | 26.7 | 24.3 | — | 5.5% | 8.6% | 5.7% | 7.5 |
| SNDA | $682M | -66.5 | 45.0 | — | 89.1% | -4.9% | -6.5% | -1.7% | 22.3 |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 21 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ENSG stacks up against sector leader Encompass Health Corporation.
Start ComparisonThe Ensign Group, Inc.'s current P/E ratio is 36.7x. The historical average is 18.9x. This places it at the 100th percentile of its historical range.
The Ensign Group, Inc.'s current EV/EBITDA is 26.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.4x.
The Ensign Group, Inc.'s return on equity (ROE) is 16.9%. The historical average is 20.3%.
Based on historical data, The Ensign Group, Inc. is trading at a P/E of 36.7x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
The Ensign Group, Inc.'s current dividend yield is 0.11%.
The Ensign Group, Inc. has 20.5% gross margin and 8.4% operating margin.
The Ensign Group, Inc.'s Debt/EBITDA ratio is 3.9x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.